
																
																	Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years
																
																
																
															Keywords: Cost-effectiveness; Osteoporosis; Postmenopausal women; Risedronate; Strontium ranelate;